149 related articles for article (PubMed ID: 35263165)
41. Aerosolized pentamidine as pneumocystis prophylaxis after bone marrow transplantation is inferior to other regimens and is associated with decreased survival and an increased risk of other infections.
Vasconcelles MJ; Bernardo MV; King C; Weller EA; Antin JH
Biol Blood Marrow Transplant; 2000; 6(1):35-43. PubMed ID: 10707997
[TBL] [Abstract][Full Text] [Related]
42. Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial. UK Medical Research Council Adult and Children's Leukaemia Working Parties.
Burnett AK; Goldstone AH; Stevens RM; Hann IM; Rees JK; Gray RG; Wheatley K
Lancet; 1998 Mar; 351(9104):700-8. PubMed ID: 9504514
[TBL] [Abstract][Full Text] [Related]
43. Pulmonary function changes 100 days and one year after bone marrow transplantation.
Badier M; Guillot C; Delpierre S; Vanuxem P; Blaise D; Maraninchi D
Bone Marrow Transplant; 1993 Nov; 12(5):457-61. PubMed ID: 8298556
[TBL] [Abstract][Full Text] [Related]
44. Bloodstream infections can develop late (after day 100) and/or in the absence of neutropenia in children receiving allogeneic bone marrow transplantation.
Romano V; Castagnola E; Dallorso S; Lanino E; Calvi A; Silvestro S; Morreale G; Giacchino R; Dini G
Bone Marrow Transplant; 1999 Feb; 23(3):271-5. PubMed ID: 10084259
[TBL] [Abstract][Full Text] [Related]
45. Risky health behaviors and subsequent late mortality after blood or marrow transplantation: a BMTSS report.
Balas N; Richman J; Landier W; Shrestha S; Bruxvoort KJ; Hageman L; Meng Q; Ross E; Bosworth A; Te HS; Wong FL; Bhatia R; Forman SJ; Armenian SH; Weisdorf DJ; Bhatia S
Blood Adv; 2023 Nov; 7(22):7028-7044. PubMed ID: 37682779
[TBL] [Abstract][Full Text] [Related]
46. A comparison of related donor peripheral blood and bone marrow transplants: importance of late-onset chronic graft-versus-host disease and infections.
Anderson D; DeFor T; Burns L; McGlave P; Miller J; Wagner J; Weisdorf D
Biol Blood Marrow Transplant; 2003 Jan; 9(1):52-9. PubMed ID: 12533742
[TBL] [Abstract][Full Text] [Related]
47. Reduction in Late Mortality Among Patients With Multiple Myeloma Treated With Autologous Peripheral Blood Stem Cell Transplantation-A Blood or Marrow Transplant Survivor Study Report.
Giri S; Chen Y; Wu J; Hageman L; Richman J; Francisco L; Landier W; Costa L; McDonald A; Murdaugh D; Wong FL; Weisdorf DJ; Forman SJ; Arora M; Armenian SH; Bhatia S
Transplant Cell Ther; 2021 Oct; 27(10):840.e1-840.e7. PubMed ID: 34153501
[TBL] [Abstract][Full Text] [Related]
48. Bone marrow transplantation for peripheral T-cell lymphoma in children and adolescents.
Gordon BG; Warkentin PI; Weisenburger DD; Vose JM; Sanger WG; Strandjord SE; Anderson JR; Verdirame JD; Bierman PJ; Armitage JO
Blood; 1992 Dec; 80(11):2938-42. PubMed ID: 1450419
[TBL] [Abstract][Full Text] [Related]
49. Development of a biologically distinct EBV-related lymphoproliferative disorder following autologous bone marrow transplantation for an EBV-negative post-renal allograft Burkitt's lymphoma.
Lohrisch CA; Nevill TJ; Barnett MJ; Hogge DE; Connors JM; Keown PA; Gascoyne RD
Leuk Lymphoma; 2000 Sep; 39(1-2):195-201. PubMed ID: 10975399
[TBL] [Abstract][Full Text] [Related]
50. Clonal karyotypic hematopoietic cell abnormalities occurring after autologous bone marrow transplantation for Hodgkin's disease and non-Hodgkin's lymphoma.
Traweek ST; Slovak ML; Nademanee AP; Brynes RK; Niland JC; Forman SJ
Blood; 1994 Aug; 84(3):957-63. PubMed ID: 8043877
[TBL] [Abstract][Full Text] [Related]
51. Successful allogeneic bone marrow transplantation for early relapse after autologous bone marrow transplantation in two cases of aggressive high-grade non-Hodgkin's lymphoma.
Moreau P; Méchinaud F; Mahé B; Le Tortorec S; Rapp MJ; Maisonneuve H; Harousseau JL; Milpied N
Bone Marrow Transplant; 1996 Sep; 18(3):665-7. PubMed ID: 8879639
[TBL] [Abstract][Full Text] [Related]
52. Liver disease during the first post-transplant year in bone marrow transplantation recipients: retrospective study.
Kim BK; Chung KW; Sun HS; Suh JG; Min WS; Kang CS; Sim SI; Shin WS; Kim CC
Bone Marrow Transplant; 2000 Jul; 26(2):193-7. PubMed ID: 10918430
[TBL] [Abstract][Full Text] [Related]
53. Late mortality in survivors of autologous hematopoietic-cell transplantation: report from the Bone Marrow Transplant Survivor Study.
Bhatia S; Robison LL; Francisco L; Carter A; Liu Y; Grant M; Baker KS; Fung H; Gurney JG; McGlave PB; Nademanee A; Ramsay NK; Stein A; Weisdorf DJ; Forman SJ
Blood; 2005 Jun; 105(11):4215-22. PubMed ID: 15701723
[TBL] [Abstract][Full Text] [Related]
54. Feasibility and results of bone marrow transplantation after remission induction and intensification chemotherapy in de novo acute myeloid leukemia. Catalan Group for Bone Marrow Transplantation.
Sierra J; Brunet S; Grañena A; Olivé T; Bueno J; Ribera JM; Petit J; Besses C; Llorente A; Guardia R; Macía J; Rovira M; Badell I; Vela E; Díaz de Heredia C; Vivancos P; Carreras E; Feliu E; Montserrat E; Julía A; Cubells J; Rozman C; Domingo A; Ortega JJ
J Clin Oncol; 1996 Apr; 14(4):1353-63. PubMed ID: 8648394
[TBL] [Abstract][Full Text] [Related]
55. Autologous bone marrow transplantation in high-risk remission B-lineage acute lymphoblastic leukemia using a cocktail of three monoclonal antibodies (BA-1/CD24, BA-2/CD9, and BA-3/CD10) plus complement and 4-hydroperoxycyclophosphamide for ex vivo bone marrow purging.
Uckun FM; Kersey JH; Haake R; Weisdorf D; Ramsay NK
Blood; 1992 Feb; 79(4):1094-104. PubMed ID: 1531306
[TBL] [Abstract][Full Text] [Related]
56. High-dose therapy and blood or marrow transplantation for non-Hodgkin lymphoma with central nervous system involvement.
Kasamon YL; Jones RJ; Piantadosi S; Ambinder RF; Abrams RA; Borowitz MJ; Morrison C; Smith BD; Flinn IW
Biol Blood Marrow Transplant; 2005 Feb; 11(2):93-100. PubMed ID: 15682069
[TBL] [Abstract][Full Text] [Related]
57. Causes and risk factors for liver injury following bone marrow transplantation.
Ozdoğan O; Ratip S; Ahdab YA; Dane F; Ahdab HA; Imeryüz N; Tözün N
J Clin Gastroenterol; 2003; 36(5):421-6. PubMed ID: 12702986
[TBL] [Abstract][Full Text] [Related]
58. [Reconstitution of peripheral blood lymphocytes in patients treated with bone marrow transplantation: comparison between allogeneic and autologous transplantation].
Parra C; Roldán E; Rodríguez C; Pérez de Oteyza J; Oteho E; López J; Maldonado MS; García Laraña J; Muñoz A; Odriozola J; Brieva JA
Med Clin (Barc); 1999 Jun; 113(1):1-5. PubMed ID: 10422068
[TBL] [Abstract][Full Text] [Related]
59. Long-term outcome and late effects in patients transplanted with mobilised blood or bone marrow: a randomised trial.
Friedrichs B; Tichelli A; Bacigalupo A; Russell NH; Ruutu T; Shapira MY; Beksac M; Hasenclever D; Socié G; Schmitz N
Lancet Oncol; 2010 Apr; 11(4):331-8. PubMed ID: 20117965
[TBL] [Abstract][Full Text] [Related]
60. Renal function after autologous bone marrow transplantation in children: a long-term prospective study.
Frisk P; Bratteby LE; Carlson K; Lönnerholm G
Bone Marrow Transplant; 2002 Jan; 29(2):129-36. PubMed ID: 11850707
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
